The global Mesenchymal Stem Cells (MSCs) Market, valued at US$ 3.2 billion in 2022, is projected to grow at a robust compound annual growth rate (CAGR) of 12.7% from 2023 to 2031, surpassing US$ 10.1 billion by 2031. MSCs, multipotent stem cells derived from bone marrow, adipose tissue, and umbilical cord, are used in regenerative medicine for conditions like osteoarthritis, cardiovascular...